No longer lost in translation
LA JOLLA, CA—Mouse models have advanced our understanding of immune function and disease in many ways but they have failed
Tumor immune fitness determines survival of lung cancer patients
LA JOLLA, CA—In recent years, immunotherapy, a new form of cancer therapy that rouses the immune system to attack tumor
La Jolla Institute scientist receives grant from the Arthritis National Research Foundation
LA JOLLA, CA—The Arthritis National Research Foundation (ANRF) has awarded La Jolla Institute researcher Michela Locci, Ph.D., a $100,000 research
It takes a village
Rarely in view of the general public, a small but unique group of La Jolla Institute employees works passionately to
La Jolla Institute researcher honored with 2016 Distinguished Scientist Award from American Heart Association
LA JOLLA, CA—Klaus Ley, M.D., professor and head of the Division of Inflammation Biology at the La Jolla Institute for
La Jolla Institute named one of San Diego’s healthiest companies
SAN DIEGO – (May 13, 2013) In the latest in a growing series of recognitions, La Jolla Institute for Immunology
La Jolla Institute discovers new player critical to unleashing T cells against disease
SAN DIEGO – June 23, 2013 A major study from researchers at the La Jolla Institute for Immunology provides new
Potential new drug target for the treatment of rheumatoid arthritis
LA JOLLA, CA — Researchers at the La Jolla Institute for Immunology, in collaboration with colleagues the University of California,